Embecta Corp.
EMBCNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.08B | $1.12B | $1.12B | $1.13B | $1.17B | $1.09B |
| Operating income | $242.1M | $166.8M | $221.5M | $309.6M | $492.0M | $486.5M |
| Net income | $95.4M | $78.3M | $70.4M | $223.6M | $414.8M | $427.6M |
| Total assets | $1.09B | $1.29B | $1.21B | $1.09B | $788.0M | — |
| Total liabilities | — | — | — | — | — | — |
| Equity | −$650.6M | −$738.3M | −$821.7M | −$891.4M | $594.3M | $572.2M |
| EPS (diluted) | $1.62 | $1.34 | $1.22 | $3.89 | $7.28 | $7.50 |
| Shares out. | 58.5M | 58.1M | 57.3M | 57.1M | 57.0M | 57.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 22.4%
- Net margin
- 8.8%
- Return on equity
- −14.7%
- Return on assets
- 8.7%
- Return on capital (ROCE)
- 29.2%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $-11.12
- Revenue growth (YoY)
- −3.8%
- Net income growth (YoY)
- 21.8%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −8.8%clean
- Piotroski F-Score
- 7/8strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 3 good- Negative shareholder equity
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Revenue declined year-over-year
- Operating margin is positive
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Nov 29, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- River Road Asset Management, LlcPassive (13G)May 27, 2026
- Yacktman Asset Management LpPassive (13G)May 5, 2026
- American Century Investment Management IncPassive (13G)May 1, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Blackrock, Inc.Passive (13G)Jul 18, 2025
- Flynn James EPassive (13G)May 13, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 7.1M | 1.4 | +18.0% |
| Apr 30, 2026 | 6.0M | 8.5 | +4.3% |
| Apr 15, 2026 | 5.8M | 8.4 | +9.9% |
| Mar 31, 2026 | 5.3M | 5.5 | -6.0% |
| Mar 13, 2026 | 5.6M | 6.5 | +19.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Regulation FD disclosureMay 15, 2026
- Results of operationsMay 5, 2026
- Entered a material agreement · Regulation FD disclosureMar 20, 2026
- Shareholder voteFeb 13, 2026
- Results of operationsFeb 5, 2026
- Results of operationsNov 25, 2025
- Director / officer changeNov 17, 2025
- Results of operationsAug 8, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/AMay 27, 2026
- SDMay 22, 2026
- 8-KCURRENT REPORTMay 15, 2026
- SCHEDULE 13GMay 5, 2026
- 10-QMay 5, 2026
- 8-KMay 5, 2026
- SCHEDULE 13G/AMay 1, 2026
- SCHEDULE 13GApr 29, 2026
- SCHEDULE 13G/AMar 26, 2026
- 8-KCURRENT REPORTMar 20, 2026
- 4Feb 13, 2026
- 4Feb 13, 2026
- 4Feb 13, 2026
- 4Feb 13, 2026
- 4Feb 13, 2026